Clinical trials · Birmingham, AL
Refractory Malignant Solid Neoplasm clinical trials in Birmingham
We’re tracking 3 recruiting refractory malignant solid neoplasm studies with a site in or near Birmingham — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Birmingham
- NCT04851119RecruitingPhase 1/Phase 2
Tegavivint for kids and young adults with hard-to-treat solid tumors
This early-phase study tests tegavivint to see how well it works and how safe it is for children and young adults with solid cancers that have come back or are not responding. It may be an option if your tumor type (including certain lymphomas or desmoid tumors) matches the study’s rules.
Birmingham, AlabamaAges 1–30 - NCT02402244Recruiting
Caring registry study for children and young people with cancer
This study keeps a careful record of children, teens, and young adults with cancer (and some related growths) and may follow them over time. It helps researchers better track outcomes and future contact so care can improve.
Birmingham, AlabamaAges Up to 25 years - NCT05208762RecruitingPhase 1
PD-L1 antibody drug study for advanced lung and head/neck cancers
This Phase 1 trial tests a new experimental drug (PF-08046054/SGN-PDL1V) in people with advanced solid tumors that have not responded to standard treatment or can’t use it. It is designed to see how the drug works and how safe it is, with a focus on tumors that have PD-L1 seen on prior lab testing.
Birmingham, AlabamaAges 18 years+
Hear when a new Refractory Malignant Solid Neoplasm trial opens near Birmingham, AL
We’ll email you when one opens near Birmingham, AL — at most once a week, no account needed, unsubscribe anytime.
Refractory Malignant Solid Neoplasm trials in other cities
Where these studies are running near Birmingham
Institutions with a site for the recruiting refractory malignant solid neoplasm studies listed above.
- Children's Hospital of Alabama · 2 studies
- University of Alabama at Birmingham
What taking part in a refractory malignant solid neoplasm study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting refractory malignant solid neoplasm studies in Alabama.
Common questions
- Are there refractory malignant solid neoplasm clinical trials near Birmingham?
- Yes. We're currently tracking 3 recruiting refractory malignant solid neoplasm studies with a site near Birmingham, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a refractory malignant solid neoplasm study near Birmingham?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Birmingham to take part?
- Not necessarily. These studies have a site near Birmingham, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a refractory malignant solid neoplasm trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New refractory malignant solid neoplasm studies open near Birmingham regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.